The Cooper Companies (COO) is experiencing some fluctuations with a mixture of positive and negative performance indicators. There are concerns over the organization's mixed fundamentals, and its price target has been slashed by both
JP Morgan and
Bank of America. Their stock, which has underperformed the healthcare sector, saw a dip even though their Q2 earnings apparently surpassed estimates. The company, which has a strong reliance on international revenue, slashed the full-year growth forecast, causing the stock to sink further. However, Cooper still maintains some positive attributes, achieving growth for Q3 2025 despite underperformations in other areas. They demonstrated strong earnings for their Q2 2025 report, albeit with a stock dip. On another positive note, they have reported strong core growth amid fertility woes, including surpassing Q2 earnings and revenue estimates.
Cooper Companies (COO) also plans to report its third quarter 2025 financial results on AUG 27, 2025.
The Cooper Companies COO News Analytics from Mon, 29 Nov 2021 08:00:00 GMT to Fri, 25 Jul 2025 11:55:24 GMT -
Rating -3
- Innovation 0
- Information 2
- Rumor -2
